Published in Cancer on June 01, 1993
Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study. Br J Cancer (2003) 1.62
Costs of home versus inpatient treatment for fever and neutropenia: analysis of a multicenter randomized trial. J Clin Oncol (2011) 1.34
Safety of early discharge for low-risk patients with febrile neutropenia: a multicenter randomized controlled trial. J Clin Oncol (2011) 1.26
Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones. Antimicrob Agents Chemother (1994) 1.20
The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients. Support Care Cancer (2013) 1.05
Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients. Support Care Cancer (2004) 1.01
Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients. Br J Cancer (2011) 0.97
Health-related quality of life anticipated with different management strategies for febrile neutropenia in adult cancer patients. Support Care Cancer (2012) 0.90
Health-related quality of life anticipated with different management strategies for paediatric febrile neutropaenia. Br J Cancer (2011) 0.86
Risk-adapted strategy for the management of febrile neutropenia in cancer patients. Support Care Cancer (2007) 0.85
Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients. Br J Cancer (2011) 0.84
Oral moxifloxacin for outpatient treatment of low-risk, febrile neutropenic patients. Support Care Cancer (2009) 0.82
National Cancer Institute Cancer Center designation and 30-day mortality for hospitalized, immunocompromised cancer patients. Cancer Invest (2010) 0.79
Risk assessment and risk-based therapy in febrile neutropenic patients. Eur J Clin Microbiol Infect Dis (1998) 0.75
Management of febrile neutropenia in low risk cancer patients. Thorax (2000) 0.75
Ceftriaxone in the outpatient treatment of cancer patients with fever and neutropenia. Eur J Clin Microbiol Infect Dis (1998) 0.75
The use of quinolones as therapy in granulocytopenic cancer patients. Comparison with other antimicrobials. Drugs (1995) 0.75
Fluorescence detection in automated DNA sequence analysis. Nature (1986) 12.53
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet (2009) 7.96
Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Lancet (2003) 6.77
The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1. Nucleic Acids Res (1983) 4.06
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol (2000) 3.69
ABO incompatible renal transplantation without antibody removal using conventional immunosuppression alone. Am J Transplant (2014) 3.29
Incidence, correlates and predictors of post-traumatic stress disorder in the pregnancy after stillbirth. Br J Psychiatry (2001) 3.14
Skeletal metastases in colorectal carcinomas: a Saskatchewan profile. Dis Colon Rectum (1999) 2.75
A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest (1999) 2.65
Extraskeletal osteosarcoma. A clinicopathologic review of 26 cases. Cancer (1990) 2.56
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol (1997) 2.32
Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid. Br Med J (Clin Res Ed) (1982) 2.32
Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med (1997) 2.22
New spectrum of fungal infections in patients with cancer. Rev Infect Dis (1989) 2.16
Trichosporon beigelii infection: a review. Rev Infect Dis (1987) 2.15
A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob Agents Chemother (1994) 2.10
Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule. Cancer (1974) 2.10
Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer (2001) 1.89
NCCN Practice Guidelines for Cancer-Related Fatigue. Oncology (Williston Park) (2000) 1.88
Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med (1982) 1.85
Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis (1998) 1.83
An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol (2012) 1.81
Labour and birth in water in England and Wales. BMJ (1995) 1.79
Influenza among hospitalized adults with leukemia. Clin Infect Dis (1997) 1.68
Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer (1995) 1.65
Preoperative chemotherapy for soft-tissue sarcomas of the extremities. Ann Surg (1990) 1.59
Direct quantitation of the number of individual penicillin-binding proteins per cell in Escherichia coli. J Bacteriol (1996) 1.57
Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents (2007) 1.57
The emerging role of Fusarium infections in patients with cancer. Medicine (Baltimore) (1988) 1.56
In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents. Antimicrob Agents Chemother (1990) 1.52
Controlled clinical trial of cannabidiol in Huntington's disease. Pharmacol Biochem Behav (1991) 1.51
Soft tissue sarcomas of the head and neck in adolescents and adults. Am J Surg (1986) 1.50
Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. J Clin Oncol (2001) 1.47
Maternal age, morphology, development and chromosome abnormalities in over 6000 cleavage-stage embryos. Reprod Biomed Online (2007) 1.47
Adriamycin cardiomyopathy--risk factors. Cancer (1977) 1.46
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep (1976) 1.45
Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas. Am J Clin Oncol (1998) 1.45
Inhibition of prostacyclin release by endothelial binding anticardiolipin antibodies in thrombosis-prone patients with systemic lupus erythematosus and the antiphospholipid syndrome. Br J Rheumatol (1994) 1.45
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol (1999) 1.45
The association of HLA-B8 with visceral disease in systemic sclerosis. Clin Exp Immunol (1978) 1.45
Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor. Ann Oncol (2010) 1.42
Blood lead, intelligence, reading attainment, and behaviour in eleven year old children in Dunedin, New Zealand. J Child Psychol Psychiatry (1988) 1.42
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study. J Natl Cancer Inst (1991) 1.40
Cocaine use by senior medical students. Am J Psychiatry (1989) 1.39
The E. coli cell surface specifically prevents the initiation of DNA replication at oriC on hemimethylated DNA templates. Cell (1990) 1.38
Hypofractionation reduces the therapeutic ratio in early glottic carcinoma. Int J Radiat Oncol Biol Phys (1988) 1.38
An automated method for recording the Westergren erythrocyte sedimentation rate. J Clin Pathol (1981) 1.38
Purification and properties of carboxypeptidase G2 from Pseudomonas sp. strain RS-16. Use of a novel triazine dye affinity method. Eur J Biochem (1985) 1.38
Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis. Clin Exp Immunol (1984) 1.37
Combination chemotherapy in adult desmoid tumors. Cancer (1993) 1.36
Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function. Cancer Res (1977) 1.36
The nasopharyngeal bacterial flora in the sudden infant death syndrome. J Infect (1989) 1.36
High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence. J Clin Oncol (1997) 1.34
Comparative in-vitro activity of twenty antimicrobial agents against clinical isolates of Mycobacterium avium complex. J Antimicrob Chemother (1989) 1.32
Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer (1999) 1.31
Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol (1998) 1.29
Role of radiotherapy in sarcoma of the breast--a retrospective review of the M.D. Anderson experience. Radiother Oncol (1999) 1.29
Initiator (DnaA) protein concentration as a function of growth rate in Escherichia coli and Salmonella typhimurium. J Bacteriol (1991) 1.28
A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin. J Clin Oncol (1984) 1.28
Sarcoma of the breast: implications for extent of therapy. The M. D. Anderson experience. Surgery (1994) 1.28
Apophysial joint degeneration, disc degeneration, and sagittal curve of the cervical spine. Can they be measured reliably on radiographs? Spine (Phila Pa 1976) (1997) 1.27
Inspiratory coactivation of the genioglossus enlarges retroglossal space in laryngectomized humans. J Appl Physiol (1985) (1996) 1.26
Doxorubicin-induced congestive heart failure in adults. Cancer (1985) 1.26
Incidence of childhood-onset Type 1 diabetes mellitus in Devon and Cornwall, England, 1975-1996. Diabet Med (1999) 1.25
Cardiotoxicity in patients receiving transtuzumab (Herceptin): primary toxicity, synergistic or sequential stress, or surveillance artifact? Semin Oncol (1999) 1.25
Triazine-dye affinity; chromatography. Biochem Soc Trans (1981) 1.24
Metal ion-promoted binding of proteins to immobilized triazine dye affinity adsorbents. Biochim Biophys Acta (1982) 1.22
Of mice and men: divergent risks of teriparatide-induced osteosarcoma. Osteoporos Int (2009) 1.22
Chemotherapy for metastatic carcinoid tumors: experiences with 32 patients and a review of the literature. Cancer Treat Rep (1977) 1.21
Comparison of STD prevalences in the Mwanza, Rakai, and Masaka trial populations: the role of selection bias and diagnostic errors. Sex Transm Infect (2003) 1.21
Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. JAMA (1988) 1.20
Dysosmia, dysgeusia, and nifedipine. Ann Intern Med (1985) 1.20
Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin Infect Dis (1996) 1.20
Pharmacokinetics and metabolism of adriamycin in man. Clin Pharmacol Ther (1973) 1.19
Pseudomonas putida. Newly recognized pathogen in patients with cancer. Am J Med (1987) 1.18
Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer. J Clin Oncol (2001) 1.18
Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors. J Clin Oncol (1994) 1.17
Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia. J Clin Oncol (2001) 1.17
In vitro replication of a dam methylated and non-methylated ori-C plasmid. J Mol Biol (1984) 1.17
blaVIM-2 and blaVIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program. J Clin Microbiol (2006) 1.16
Lack of effectiveness of syndromic management in targeting vaginal infections in pregnancy in Entebbe, Uganda. Sex Transm Infect (2006) 1.15
Testicular cancer incidence trends in the USA (1975-2004): plateau or shifting racial paradigm? Public Health (2008) 1.15
Extraskeletal myxoid chondrosarcoma. Long-term experience with chemotherapy. Am J Clin Oncol (1995) 1.15
Mediation of proliferating cell nuclear antigen (PCNA)-dependent DNA replication through a conserved p21(Cip1)-like PCNA-binding motif present in the third subunit of human DNA polymerase delta. J Biol Chem (2001) 1.14
Myxoid liposarcoma. Experience with chemotherapy. Cancer (1994) 1.13
Aetiology of sexually transmitted infections and response to syndromic treatment in southwest Uganda. Sex Transm Infect (2005) 1.13
Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice. Cancer (1998) 1.12
The small for gestational age infant: accelerated or delayed pulmonary maturation? Increased or decreased survival? Pediatrics (1995) 1.11
Elevated von Willebrand factor antigen in systemic sclerosis: relationship to visceral disease. Br J Rheumatol (1988) 1.11
Evaluation of blood donor deferral causes in the Trinidad and Tobago National Blood Transfusion Service. Transfus Med (2009) 1.10
Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases. Cancer (1993) 1.09
Silent hydronephrosis/pyonephrosis due to upper urinary tract calculi in spinal cord injury patients. Spinal Cord (2000) 1.09
Arterial occlusion: management of giant cell tumor and aneurysmal bone cyst. AJR Am J Roentgenol (1981) 1.09
Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial. Arch Intern Med (2000) 1.09
Right phrenic nerve palsy as a complication of indwelling central venous catheters. Thorax (1997) 1.08
Use of the Ottawa ankle rules by nurse practitioners. J Accid Emerg Med (1998) 1.08
Acinetobacter calcoaceticus septicemia in patients with cancer. South Med J (1985) 1.08
c-Jun stimulates origin-dependent DNA unwinding by polyomavirus large Tantigen. EMBO J (1996) 1.08
In vitro susceptibilities of Nocardia species to newer antimicrobial agents. Antimicrob Agents Chemother (1988) 1.07
The relationship of defective cell-mediated immunity to visceral disease in systemic sclerosis. Clin Exp Immunol (1977) 1.07